The Malaysian Insider reported that China will introduce a blacklist of drug makers and medical device manufacturers found to have paid bribes as it extends a crackdown on graft in the healthcare sector.

The Insider said firms on the list once will be banned for two years from selling within the region where they were implicated. Those appearing on the list twice in five years will be banned nationally, also for two years.

The Insider noted that healthcare departments will compile lists of offending manufacturers, agents and individuals, which will be published online. The list will come into effect from the beginning of March.

To read The Malasian Insider article click here.